Treatment strategy for metastatic breast cancer with estrogen receptor-positive tumor

被引：0
|
作者：
Hirotaka Iwase
机构：
[1] Kumamoto University,Department of Breast and Endocrine Surgery
来源：
International Journal of Clinical Oncology | 2015年 / 20卷
关键词：
Endocrine Therapy; Human Epidermal Growth Factor Receptor; Metastatic Breast Cancer; Letrozole; Exemestane;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：249 / 252
页数：3
相关论文
共 50 条
  • [41] Late Recurrences After Estrogen Receptor-Positive Breast Cancer
    Narod, Steven A.
    Giannakeas, Vasily
    Sopik, Victoria
    [J]. JAMA ONCOLOGY, 2020, 6 (02) : 301 - +
  • [42] The Intestinal Microbiome and Estrogen Receptor-Positive Female Breast Cancer
    Kwa, Maryann
    Plottel, Claudia S.
    Blaser, Martin J.
    Adams, Sylvia
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (08)
  • [43] Leptin as a Potential Target for Estrogen Receptor-Positive Breast Cancer
    Yom, Cha Kyong
    Lee, Kyung-Min
    Han, Wonshik
    Kim, Sung-Won
    Kim, Hee Sung
    Moon, Byung In
    Jeong, Ku-Young
    Im, Seock-Ah
    Noh, Dong-Young
    [J]. JOURNAL OF BREAST CANCER, 2013, 16 (02) : 138 - 145
  • [44] Estrogen Receptor Bio-Activities Determine Clinical Endocrine Treatment Options in Estrogen Receptor-Positive Breast Cancer
    Xia, Song
    Lin, Qiong
    [J]. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2022, 21
  • [45] Sacituzumab Govitecan in Hormone Receptor-Positive Metastatic Breast Cancer
    Sg, Nithin
    Gogia, Ajay
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (08)
  • [46] Fulvestrant in management of hormone receptor-positive metastatic breast cancer
    Shafaee, Maryam Nemati
    Ellis, Matthew James
    [J]. FUTURE ONCOLOGY, 2018, 14 (18) : 1789 - 1800
  • [47] Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer
    Datta, Jharna
    Willingham, Natalie
    Manouchehri, Jasmine M.
    Schnell, Patrick
    Sheth, Mirisha
    David, Joel J.
    Kassem, Mahmoud
    Wilson, Tyler A.
    Radomska, Hanna S.
    Coss, Christopher C.
    Bennett, Chad E.
    Ganju, Ramesh K.
    Sardesai, Sagar D.
    Lustberg, Maryam
    Ramaswamy, Bhuvaneswari
    Stover, Daniel G.
    Cherian, Mathew A.
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [48] Impact of adding the multikinase inhibitor sorafenib to endocrine therapy in metastatic estrogen receptor-positive breast cancer
    Massarweh, Suleiman
    Moss, Jessica
    Wang, Chi
    Romond, Edward
    Slone, Stacey
    Weiss, Heidi
    Karabakhtsian, Rouzan G.
    Napier, Dana
    Black, Esther P.
    [J]. FUTURE ONCOLOGY, 2014, 10 (15) : 2435 - 2448
  • [49] The Evolving Use of SERDs in Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer
    Jeselsohn, Rinath M.
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (07) : 428 - 431
  • [50] Efficacy of fulvestrant in treating postmenopausal patients with estrogen receptor-positive metastatic breast cancer and prognostic analysis
    Li, Tao
    Jiao, Lianghe
    [J]. JOURNAL OF BUON, 2021, 26 (01): : 189 - 195
12345